David J. Wambeke - 01 Mar 2026 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Role: Chief Business Officer
Signature: /s/ Emily Johns, by Power of Attorney
Issuer symbol: NMTC
Transactions as of: 01 Mar 2026
Net transactions value: +$670,400
Form type: 4
Filing time: 03 Mar 2026, 08:49:19 UTC
Previous filing: 03 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wambeke David J.	Chief Business Officer	7599 ANAGRAM DRIVE, EDEN PRAIRIE	/s/ Emily Johns, by Power of Attorney	03 Mar 2026	0001971798

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NMTC	Common Stock	Purchase	$670,400	+1,000,000		$0.6704	1,000,000	01 Mar 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NMTC	Option to Purchase Common Stock	Award	$0	+500,000		$0.000000	500,000	01 Mar 2026	Common Stock	500,000	$0.6704	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% will vest on March 1, 2027, and the remaining 75% will vest in 12 equal installments on the last day of each quarter beginning on March 31, 2027.